These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3859687

  • 1. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW, Bartlett GL.
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [Abstract] [Full Text] [Related]

  • 2. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
    Christensen ND, Kreider JW, Bartlett GL, Horetsky RL.
    Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
    [Abstract] [Full Text] [Related]

  • 3. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW, Bartlett GL, Boyer CM, Purnell DM.
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
    Howell LE, Kreider JW, Bartlett GL.
    J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL, Lembo TM, Welch DR.
    Cancer Res; 1988 Jan 15; 48(2):399-404. PubMed ID: 2825974
    [Abstract] [Full Text] [Related]

  • 13. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW, Kuperman O, Lucas ZJ.
    J Immunol; 1975 Nov 15; 115(5):1269-76. PubMed ID: 1080776
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1982 Jun 15; 42(6):2211-5. PubMed ID: 7042079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
    Frey AB.
    J Immunol; 1996 May 15; 156(10):3841-9. PubMed ID: 8621922
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
    Hoon DB, Ziola B, Ramshaw I.
    Cancer Res; 1984 Jun 15; 44(6):2406-9. PubMed ID: 6722781
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun 15; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.